The Effect of Helfer Skin Tap Technique During Tetanus Injection in Pregnant Women
NCT ID: NCT05761340
Last Updated: 2023-03-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
65 participants
INTERVENTIONAL
2021-08-30
2022-03-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The aim of the study was to determine the effect of Helfer skin tap technique on pain reduction and hemodynamic parameters during tetanus injection in pregnant women. This study was conducted on pregnant women who applied to the Family Health Center to get a tetanus vaccine. The Helfer skin tap and standard application groups each included 33 and 32 pregnant women, respectively.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness of Helfer Skin Tap Technique and ShotBlocker Technique
NCT06246266
The Effect of Mechanical Vibration and Helfer Skin Tap Technique on Procedural Pain in Infants During Vaccination
NCT06454812
Vibration and Shotblocker Use in Pregnant Women While Giving Tetanus + Diphtheria Vaccine
NCT05701904
The Impact of Helfer Skin Tap and ShotBlocker Techniques on Emotional Responses to Intramuscular Injections in Children
NCT06851182
The Effect of Distraction Techniques Used in Intramuscular (IM) Injections on Pain in Adolescents Presenting to the Emergency Department With Dysmenorrhea: A Randomized Controlled Study
NCT06842329
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The study aimed to determine the effect of Helfer skin tap technique on pain reduction and hemodynamic parameters during tetanus injection in pregnant women. This study was a randomized clinical trial conducted in Manisa Soma Family Health Center in Turkey. The study was conducted with 65 pregnant women who got tetanus vaccine. Tetanus vaccine was administered using the Helfer skin tap techniques to 33 of the pregnant women and standard IM injection technique to 32 women. The pain was evaluated immediately after vaccination and hemodynamic parameters were examined before and immediately after the vaccine.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Helfer Skin Tap Group
Pregnant women were vaccinated against tetanus with the Helfer skin tap technique.The pain was evaluated with Number rating scale immediately after the procedure and also hemodynamic parameters were measured before and after the vaccination. A total of 33 pregnant women completed the study in the Helfer skin tap group
Helfer skin tap injection technique
1. Place the patient in a seated position and open his right arm to inject into the deltoid muscle.
2. After determining the injection site, use the tips of the dominant hand fingers to hit the skin (about 15 strokes) for about five seconds to soften the muscles.
3. After cleaning the skin with alcohol, remove the syringe cover from the dominant hand. Make a V with the non-dominant hand and hit the skin three times.
4. During the third stroke, prick the syringe into the muscle at 90 degrees angle at the same time.
5. After aspiration, continue to hit the skin with the tips of the non-dominant hand fingers while injecting the drug with the dominant hand at a rate of 1 ml / 10 seconds.
6. After injecting the drug, make the non-dominant hand V-shaped and hit the skin three times, pulling the syringe needle out at the same time during the third stroke
Standard Application Group
Pregnant women were vaccinated against tetanus with thestandard application technique.The pain was evaluated with Number rating scale. The pain was evaluated immediately after vaccination and hemodynamic parameters were examined before and after the vaccination. A total of 32 pregnant women completed the study in the standard application group.
Standard Injection technique
1. Place the patient in a seated position and open his right arm to inject into the deltoid muscle area.
2. After determining the injection site, prepare the skin with alcohol.
3. Grasp the skin with the thumb and index finger of the non-dominant hand and prick the syringe into the muscle at a 90-degree angle.
4. After aspiration, inject the drug with the dominant hand at a rate of 1 ml /10 seconds.
5. Remove the syringe needle 10 seconds after the drug is consumed
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Helfer skin tap injection technique
1. Place the patient in a seated position and open his right arm to inject into the deltoid muscle.
2. After determining the injection site, use the tips of the dominant hand fingers to hit the skin (about 15 strokes) for about five seconds to soften the muscles.
3. After cleaning the skin with alcohol, remove the syringe cover from the dominant hand. Make a V with the non-dominant hand and hit the skin three times.
4. During the third stroke, prick the syringe into the muscle at 90 degrees angle at the same time.
5. After aspiration, continue to hit the skin with the tips of the non-dominant hand fingers while injecting the drug with the dominant hand at a rate of 1 ml / 10 seconds.
6. After injecting the drug, make the non-dominant hand V-shaped and hit the skin three times, pulling the syringe needle out at the same time during the third stroke
Standard Injection technique
1. Place the patient in a seated position and open his right arm to inject into the deltoid muscle area.
2. After determining the injection site, prepare the skin with alcohol.
3. Grasp the skin with the thumb and index finger of the non-dominant hand and prick the syringe into the muscle at a 90-degree angle.
4. After aspiration, inject the drug with the dominant hand at a rate of 1 ml /10 seconds.
5. Remove the syringe needle 10 seconds after the drug is consumed
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* being pregnant,
* having no infection, scar tissue, or incision, and receiving parenteral treatment in their injection area
* having no history of pain in their injection are
* applying for tetanus vaccine
* speaking Turkish
* voluntariness.
Exclusion Criteria
* not being pregnant
* having a vaccination other than tetanus,
* having pain or a local infection prior to vaccination,
* having a circulatory disorder, peripheral vascular disease,
* cognitive and psychological problems,
* using painkillers at least 6 hours before the procedure,
* refusing to participate
18 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Celal Bayar University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Aslı Karakuş Selçuk, PhD
Role: PRINCIPAL_INVESTIGATOR
Manisa Celal Bayar University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Manisa Celal Bayar University
Manisa, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Celal Bayar University
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.